DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis
Objective Lipotoxic hepatocyte injury is a primary
event in non-alcoholic
steatohepatitis (NASH), but
the mechanisms of lipotoxicity are not fully defined.
Sphingolipids and free cholesterol (FC) mediate
hepatocyte injury, but their link in NASH has not been
explored. We examined the role of free cholesterol
and sphingomyelin synthases (SMSs) that generate
sphingomyelin (SM) and diacylglycerol (DAG) in
hepatocyte pyroptosis, a specific form of programmed
cell death associated with inflammasome activation, and
NASH.
Design Wild-type
C57BL/6J mice were fed a high fat
and high cholesterol diet (HFHCD) to induce NASH.
Hepatic SMS1 and SMS2 expressions were examined in
various mouse models including HFHCD-fed
mice and
patients with NASH. Pyroptosis was estimated by the
generation of the gasdermin-D
N-terminal
fragment.
NASH susceptibility and pyroptosis were examined
following knockdown of SMS1, protein kinase C¿
(PKC¿), or the NLR family CARD domain-containing
protein 4 (NLRC4).
Results HFHCD increased the hepatic levels of SM and
DAG while decreasing the level of phosphatidylcholine.
Hepatic expression of Sms1 but not Sms2 was
higher in mouse models and patients with NASH.
FC in hepatocytes induced Sms1 expression, and
Sms1 knockdown prevented HFHCD-induced
NASH.
DAG produced by SMS1 activated PKC¿ and NLRC4
inflammasome to induce hepatocyte pyroptosis.
Depletion of Nlrc4 prevented hepatocyte pyroptosis and
the development of NASH. Conditioned media from
pyroptotic hepatocytes activated the NOD-like
receptor
family pyrin domain containing 3 inflammasome (NLRP3)
in Kupffer cells, but Nlrp3 knockout mice were not
protected against HFHCD-induced
hepatocyte pyroptosis.
Conclusion SMS1 mediates hepatocyte pyroptosis
through a novel DAG-PKC¿-
NLRC4 axis and holds
promise as a therapeutic target for NASH., This study was supported by grants from the National Research
Foundation of Korea (NRF), funded by the Ministry of Education, Science, and
Technology, Korea (2017R1E1A1A01073206: KUL, 2017R1E1A1A01074207: EHK)
and Asan Institute for Life Sciences, Korea (2018IP0557-1). We acknowledge the
support from NIH grants R01 DK113592, R01 AA024206 to AEF; grants SAF2017-
85877R and PID2019-1116691RB from Plan Nacional de I+D, Spain and by the
CIBEREHD, Instituto de Salud Carlos III, Spain; the center grant P50AA011999
Southern California Research Center for ALPD and Cirrhosis funded by NIAAA/
NIH; support from AGAUR of the Generalitat de Catalunya SGR-2017–1112 and
the ’ER stress-mitochondrial cholesterol axis in obesity-associated insulin resistance
and comorbidities’-Ayudas Fundación BBVA (35_2018) a Equipos de Investigación
Científica 2017, the Red Nacional 2018–1 02 799 T ’Enfermedades metabólicas y
cáncer’ and the Fundació Marató TV3 201916-30-31.